<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001989648</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001855747</issuerCik>
      <issuerName>Blend Labs, Inc.</issuerName>
      <secFileNumber>001-40599</secFileNumber>
      <issuerAddress>
        <com:street1>7250 REDWOOD BLVD., SUITE 300</com:street1>
        <com:city>NOVATO</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94945</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(650) 550-4810</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Tkach Oxana</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab &amp; Co., Inc.</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>101429</noOfUnitsSold>
      <aggregateMarketValue>405980.00</aggregateMarketValue>
      <noOfUnitsOutstanding>255696747</noOfUnitsOutstanding>
      <approxSaleDate>09/05/2025</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>02/20/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Lapse - See Remarks</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>BLEND LABS, INC.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>101429</amountOfSecuritiesAcquired>
      <paymentDate>02/20/2024</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>Shares on this filing were acquired and paid for from 02/20/2024 through 02/20/2025.</remarks>
    <noticeSignature>
      <noticeDate>09/05/2025</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>03/12/2025</planAdoptionDate>
      </planAdoptionDates>
      <signature>OXANA TKACH</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
